Imutrex-7.5 is a widely used disease-modifying therapy designed to control immune-mediated and inflammatory conditions such as rheumatoid arthritis and psoriasis, as well as certain cancers at different dosing regimens. It helps suppress excessive immune system activity that leads to joint damage, skin inflammation, and disease progression. By slowing disease activity and reducing inflammation, Imutrex-7.5 supports improved mobility, reduced pain, and better long-term disease control. It is commonly prescribed as part of structured treatment plans for chronic autoimmune conditions and plays a key role in maintaining remission and preventing complications.